Daily Medication Pearl: Armodafinil (Nuvigil)

Article

Armodafinil and modafinil have wake-promoting actions similar to sympathomimetic agents.

Medication Pearl of the Day: Armodafinil (Nuvigil)

Indication: Armodafinil is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).

Insight:

  • Dosing: OSA or narcolepsy 150 mg to 250 mg once a day in the morning.
  • Dosage forms: Tablets 50 mg, 150 mg, 200 mg, and 250 mg.
  • Adverse events: Most common adverse reactions (³5%) are headache, nausea, dizziness, and insomnia.
  • Mechanism of action: Armodafinil and modafinil have wake-promoting actions similar to sympathomimetic agents, including amphetamine and methylphenidate, although their pharmacologic profile is not identical to that of the sympathomimetic amines.
  • Manufacturer: Teva Pharma

Sources:

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/peopleimages.com | stock.adobe.com
Image credit: fidaolga - stock.adobe.com
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund | stock.adobe.com
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.